Dr. Emma Allott is a molecular cancer epidemiologist interested in understanding the role of lifestyle factors in cancer etiology and progression. She is a Research Assistant Professor in the Department of Nutrition at the University of North Carolina at Chapel Hill, a Visiting Scientist in the Department of Epidemiology at the Harvard T. H. Chan School of Public Health, and the Irish Cancer Society John Fitzpatrick Research Fellow at Trinity College Dublin. Her research integrates epidemiologic methods and design with molecular tumor profiling to identify mechanisms linking lifestyle factors with prostate cancer risk and progression, and to discover molecular drivers of prostate cancer racial disparities. Dr. Allott is principle investigator of several funded grants across various aspects of prostate cancer including molecular tumor classification and prognostication. She directs genomic and immunohistochemistry analyses of archival tissue specimens to generate molecular epidemiology resources, and leads a research program focused on the role of statin use, high serum cholesterol and dysregulated tumor lipid metabolism in prostate cancer progression. In addition, Dr. Allott collaborates with existing studies, based both in the US and Ireland, integrating immunohistochemistry and genome wide expression profiling with clinical and epidemiologic data in large cohorts of men with prostate cancer.